The Safety and Impact of Expanded Access to Naloxone in HIV and Primary Care Settings

  • Wermeling, Daniel (PI)

Grants and Contracts Details

Description

Dr. Wermeling will provide consultation in naloxone pharmacokinetics and drug delivery, and assessment of biological plausibility of potential adverse events related to naloxone.
StatusFinished
Effective start/end date8/1/164/30/17

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.